(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 75.08% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Cibus's revenue in 2025 is $4,751,000.On average, 2 Wall Street analysts forecast CBUS's revenue for 2025 to be $170,719,311, with the lowest CBUS revenue forecast at $159,200,485, and the highest CBUS revenue forecast at $182,238,136. On average, 2 Wall Street analysts forecast CBUS's revenue for 2026 to be $223,155,755, with the lowest CBUS revenue forecast at $215,934,999, and the highest CBUS revenue forecast at $230,376,512.
In 2027, CBUS is forecast to generate $996,980,143 in revenue, with the lowest revenue forecast at $330,091,718 and the highest revenue forecast at $1,663,868,568.